|
|
|
Mold Library Combination
Read the 5
mold advice ebooks in the
Mold Library Combination for only $49.00
[$75.00 total if bought separately]. The Combo package includes: (a)
Do-It-Best-Yourself Mold Prevention, Inspection, Testing, and
Remediation, $15; (b)
Mold Health Guide, $15; (c)
Mold Legal Guide, $15; (d)
Mold Home Remedy Recipes, $15; and (e)
Mold Monsters, $15. All helpful ebooks are delivered to your
designated email address as email attachments.
Order now!
|
To find a
Certified
Mold Inspector
in your area, please visit: Mold
Inspector.
To find a
Certified
Mold Remediator
or
Mold Contractor,
please visit:
Mold
Remediator.
To be trained and certified
as a
Certified
Mold Inspector or
Certified
Mold Remediator, please visit:
Mold
Instruction |
Coccidioides Mold
Species
Coccidioides immitis
is on the U.S. Government
Occupational Safety and Health Administration [OSHA]
list of biological agents and toxins that
have the potential to pose a severe threat
to public health and safety and that can potentially be utilized
by terrorists.
|
|
Taxonomic
Classifications
Kingdom: Fungi
Phylum: Ascomycota
Class: Euascomycetes
Order: Onygenales
Family: Onygenaceae
Genus: Coccidioides
|
|
Coccidioides immitis |
|

laboratory culture at 25°C |

laboratory culture at 37°C |

laboratory culture at 41°C |

Tissue/Exudate Form |
|
Above fungal identification is
courtesy of
http://vtpb-www.cvm.tamu.edu/vtpb/vet_micro/charts_fungi/fungi/cocci.html |
|

Culture of Coccidioides immitis |

Arthroconidia of C. immitis |
|
On Sabouraud's dextrose
agar at 25C, colonies are initially moist and glabrous, but
rapidly become suede-like to downy, greyish white in color
with a tan to brown reverse. However, considerable variation
in both growth rate and culture morphology has been noted (Rippon,
1988). Microscopic morphology shows typical single-celled,
hyaline, rectangular to barrel-shaped, alternate arthroconidia,
2.5-4.0 x 3.0-6.0 um in size, separated from each other by a
disjunctor cell. This arthroconidial state has been classified
in the genus Malbranchea and is similar to that
produced by many non-pathogenic soil fungi such as
Gymnoascus species.
WARNING: Cultures of Coccidioides immitis represent
a severe biohazard to laboratory personnel and must be handled
with extreme caution in an appropriate pathogen handling
cabinet. C. immitis is a dimorphic fungus, existing in
living tissue as spherules and endospores, and in soil or
culture in a mycelial form. Culture identification by the
exoantigen test is now the method of choice. |
|
For further mold information about
the Coccidioides mold
species please visit this website:
http://www.mycology.adelaide.edu.au |
|
|
Description and Habitats
Coccidioides
immitis is a primary fungal pathogen which resides in soil of
the desert Southwest. Like most medically-important fungi that
cause systemic disease, C. immitis demonstrates different
morphologies in its saprobic and parasitic phases, but is
distinguished from other fungal pathogens by the unique
morphogenetic features of its growth in host tissue.
Species
In
reference to the information provided found in
www.doctorfungus.org,
Coccidioides immitis is the only species included in
the genus Coccidioides.
Health Effects
Coccidioidomycosis
is a nasty tongue-twister of a name, often contracted to 'coccy',
for the disease caused by Coccidioides immitis. This
fungus thrives in dry, saline soils, and is endemic in desert
areas of the Southwestern U.S., where the disease is often called
'Valley Fever', because the organism is prevalent in the
San Joaquin Valley of Central California and
in Mexico (though it is strangely absent from the
deserts of Africa and Asia).
The process of infection, progress of
the disease, and clinical symptoms, are very similar to those of histoplasmosis, though the fungus is not intracellular, and forms
spherical structures containing spores. In culture, the same
fungus produces chains of alternate thallic-arthric conidia, and
has no known teleomorph. Millions of people in the U.S. Southwest
have contracted the disease. Fortunately, as in histoplasmosis,
most cases are benign, and healing is spontaneous. A few become
systemic, and are usually fatal if untreated or misdiagnosed. The
disseminated form of this disease is commoner among males than
females, and among people with darkly pigmented skin.
In
addition to, Coccidioidomycosis can also present as erythema nodosum or as a reactive arthritic condition which is
commonly referred to as desert rheumatism. It has been estimated,
primarily on the basis of skin tests, that there are between
25,000 and 100,000 new cases of human C. immitis infections
each year in United States. Approximately 10 in 200 of these
progress to disseminated disease. A history of recurrent
epidemics of coccidioidal infections, primarily in recreational
and urban areas of the San Joaquin Valley, has focused attention
on the need for both improved therapy and vaccine development.
A
recent Tucson news report claimed a 50% increase in the number of
reported C. immitis infections during 1999 in Pima County,
Arizona, and a 30% rise in the disease statewide. The direct cost
of medical supplies and sick leave for patients with Valley Fever
has also escalated. In Kern County, California, located near the
epicenter of the endemic region in that state, the accrued cost of
the disease from 1991 to 1995 was estimated at more than $66
million. Vaccination of persons at risk of contacting
coccidioidomycosis is a feasible approach to the control of this
insidious fungal disease. The rationale for immunoprotection is
based on the observation that natural infection by C. immitis
almost always confers lifelong immunity against the disease.
|
Geographic Distribution of Coccidioidomycosis
Coccidioidomycosis is primarily found in the desert regions
of Southern California, Arizona, Nevada, New Mexico and West
Texas. This large area is home to about 20% of the
population of the United States. It also includes some of
the most rapidly expanding cities in the nation and attracts
large numbers of visitors each year. The urban perimeters
extend further into the desert each year, as exemplified by
the Bakersfield region of California and the Phoenix-Tucson
area of Arizona. However, many cases of coccidioidomycosis
have also been reported in regions which are not
hyperendemic, such as San Diego and Los Angeles. Outbreaks
of coccidioidomycosis have occurred among archaeology
students digging in prehistoric Indian sites in Northern
California. In 1977, a major dust storm blew soil from the
San Joaquin Valley up into Northern California, including
San Francisco, Marin County, Santa Clara, and Monterey
County. Immediately following the storm, numerous cases of
coccidioidomycosis were reported in non-endemic regions of
middle and Northern California. At the time, there was some
concern that C. immitis might be able to seed and
persist in the soil in these areas, but that has not
occurred. The range of C. immitis includes West Texas and a
large part of the desert regions of Northern Mexico. A few
cases of coccidioidomycosis have also been reported in
Central and South America. The largest South American
endemic region is in Argentina where the climate is dry and
the soil conditions are similar to those in the desert
Southwest. Despite these geographic limitations, physicians
outside the endemic regions should consider
coccidioidomycosis as a possible diagnosis of a respiratory
infection if the patient has ever traveled through the
desert Southwest or lived in an endemic area. Reactivation
of a prior asymptomatic C. immitis infection is potential
concern for immunocompromised individuals.
(Source:
http://www.tigr.org/tdb/tgi/cigi/cimmitis_doc.html) |
The year 2001 has seen an interesting outbreak of this disease in
Dinosaur National Monument, Utah. Ten people who had been
working at a 'dig' developed acute respiratory coccoidioidomycosis
within two weeks of exposure. All were treated with
fluconazole, with an average hospital stay of 1.5 days, and
released apparently none the worse for their experience. New
regulations for digs at Dinosaur call for watering down of the
soil before digging, and use of approved respirators (N95). [from
Bryce Kendrick's The Fifth Kingdom]
To learn more
about this event, visit the web site:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5045a1.htm.
|
|
|
|

Histopathology of coccidioidomycosis of
lung.
Mature spherule with endospores of Coccidioides immitis, intense infiltrate of
neutrophils.
CDC/Dr. Lucille K. George (Above photo and caption is courtesy of:
http://www.med.sc.edu:85/mycology/mycology-6.htm)
|
|

Disseminated
coccidioidomycosis, caused by Coccidioides immitis. |
|
| Macroscopic
Features
Coccidioides
immitis
colonies grow rapidly. The colony morphology may be very
variable. At 25 or 37°C and on Sabouraud dextrose agar, the
colonies are moist, glabrous, membranous, and grayish initially,
later producing white and cottony aerial mycelium. With age,
colonies become tan to brown in color.
Microscopic
Features
Microscopic
appearance of the fungus depends on the temperature of
isolation:
1. At 25°C
Hyphae and arthroconidia
are produced. Hyphae are hyaline, septate and thin. Racquet
hyphae may occasionally be observed on slides prepared from
young cultures. Arthroconidia are thick-walled, barrel-shaped,
and 2-4 x 3-6 µm in size. Typically, these arthroconidia
alternate with empty disjunctor cells. On the released
arthroconidia, annular frills that are the remnants of the
disjunctor cells are observed.
2. At 37°C
Large, round, thick-walled
spherules (10-80 µm in diameter) filled with endospores (2-5 µm
in diameter) are observed. Production of spherules in vitro
requires inoculation into a special synthetic medium, such as
converse liquid medium, an incubation temperature of 37-40°C
and presence of CO2 at a concentration as high as 20%.
Coccidioides immitis
continues to grow as a mold and does not produce spherules at
any temperature unless special growth medium is provided in
vitro. This finding indicates that temperature is not the only
variable that controls the spherule formation. Thus, some
authorities prefer not to classify this fungus as thermally
dimorphic. Nevertheless, Coccidioides immitis is commonly
classified among the thermally dimorphic fungi.
The definitive
identification of an isolated Coccidioides immitis strain
requires demonstration of spherule production in vitro, use of
DNA probes, application of exoantigen tests, or demonstration of
spherule production in vivo by animal experiments. Molecular
typing studies have also been initiated and appear useful in
identification.
Laboratory
Precautions
The
arthroconidia of Coccidioides immitis are very
infectious. All manipulations should be done in a biological
safety cabinet.
Susceptibility
Amphotericin
B, itraconazole,
and voriconazole
appear active in vitro against Coccidioides immitis.
However, amphotericin B is less active against some of the
isolates for which it fails to exert fungicidal activity.
Itraconazole and voriconazole, on the other hand, do not have
any fungicidal activity at all against Coccidioides immitis.
Nikkomycins are additive to synergistic in vitro with fluconazole
or itraconazole against Coccidioides immitis.
Patients with self-limited
disease or relatively localized acute pulmonary infections
usually do not require antifungal therapy. Antifungal therapy
should be given to patients who have disseminated disease or are
under risk of complications due to their underlying immunosuppression and other factors. Amphotericin B and azoles,
such as fluconazole, itraconazole, and ketoconazole
are used for treatment of coccidioidomycosis. However, clinical
failure during antifungal therapy is not uncommon. Azoles,
particularly fluconazole, is preferred for treatment of cases
with meningitis. Available data suggest that the azole therapy
should be continued life long in cases with meningitis to
prevent relapses. Amphotericin B, if used for treatment of
meningitis, should be given via intrathecal route and for a
prolonged duration.
Animal experiments suggest
that caspofungin,
sordarins, and nikkomycins are also promising in treatment of
coccidioidomycosis.
Concomitant surgical
interventions may be required for some patients with pulmonary coccidioidomycosis as well as cases with bone and joint
involvement. |
|
The mycological information gathered and organized in
this extensive research on the
different Pathogenic Molds was sourced
out from the list of websites below:
http://www.osha.gov |
http://www.doctorfungus.org
|
http://www.mycology.adelaide.edu.au
|
http://www.mycology.net
|
http://www.dehs.umn.edu
|
http://www.mold-help.org
|
http://www.mycology.net
|
http://www.pfdb.net
|
http://www.clinical-mycology.com
|
http://www.botany.utoronto.ca
|
http://www.med.sc.edu
|
http://www.tigr.org
|
http://www.pangloss.ucsfmedicalcenter.org
|
http://www.dermnz.org
|
http://ncbi.nlm.nih.gov
|
http://www.wadsworth.org
|
http://botit.botany.wisc.edu
BROWSE THESE MOLD
SPECIES WEBPAGES---
[Home] [Up] [Mold Species] [Absidia] [Acremonium] [Alternaria] [Aspergillus] [Aureobasidium] [Basidiobolus] [Beauveria] [Bipolaris] [Blastomyces] [Candida] [Chaetomium] [Chysosporium] [Cladophialophora] [Cladosporium] [Coccidioides] [Conidiobolus] [Cryptococcus] [Cunninghamella] [Curvularia] [Drechslera] [Emmonsia] [Engyodontium] [Epidermophyton] [Exophiala] [Exserohilum] [Fonsecaeae] [Fusarium] [Histoplasma] [Lecythophora Species] [Madurella] [Microsporum] [Mucor] [Paecilomyces] [Paracoccidioides] [Penicillium] [Phialophora] [Phoma] [Rhinocladiella] [Rhizomucor] [Rhizopus] [Scedosporium] [Scopulariopsis] [Scytalidium] [Sporothrix] [Stachybotrys] [Trichoderma] [Trichophyton] [Verticillium] [Wallemia] [Wangiella dermatitidis] [Yeast] |
|
[Home] [Contact-Us] [Mold.ph Site Map] [Toxic Mold Species] [Mold Health Effects] [Mold Inspection] [Mold Remediation] [Mold Advice] [Mold-Terms-Terminology] [Definition-of-terms]
|
|
|
|